Bioprocessing of oncolytic group B adenovirus for scalable production
<p>The central aim of this thesis was to develop strategies to improve the manufacture of the group B chimeric oncolytic adenovirus, ColoAd1, which rapidly kills and lyses host cells. In attempting to improve the cellular yield of ColoAd1, this thesis therefore sought to identify host infectio...
Autor Principal: | Cooper, L |
---|---|
Outros autores: | Seymour, L |
Formato: | Thesis |
Idioma: | English |
Publicado: |
2014
|
Subjects: |
Títulos similares
-
Oncolytic Adenoviruses in Cancer Treatment
por: Ramon Alemany
Publicado: (2014-02-01) -
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
por: Marc Garcia‐Moure, et al.
Publicado: (2024-04-01) -
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
por: Janet Lei, et al.
Publicado: (2018-06-01) -
Oncolytic Replication of E1b-Deleted Adenoviruses
por: Pei-Hsin Cheng, et al.
Publicado: (2015-11-01) -
A Renaissance for Oncolytic Adenoviruses?
por: Paola Blanchette, et al.
Publicado: (2023-01-01)